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Abstract
Sendai virus V protein is not essential for virus replication in cultured cells but is essential for efficient virus replication and pathogenesis
in mice, indicating that the V protein has a luxury function to facilitate virus propagation in mice. This was discovered in the Z strain, an
egg-adapted avirulent laboratory strain. In the present study, we reexamined the function of Sendai virus V protein by generating a
V-knockout Sendai virus derived from the Hamamatsu strain, a virulent field isolate, which is an appropriate model for studying the natural
course of Sendai virus infection in mice. We unexpectedly found that the V-knockout virus propagated efficiently in mice and was as virulent
as the wild-type virus. Switching of the functionally important V unique region demonstrated that this region of the Hamamatsu strain was
also functional in a Z strain background. It thus appears that the V protein is nonsense in a field isolate of Sendai virus. However, the V
protein was required for virus growth and pathogenesis of the Hamamatsu strain in mice when the virulence of the virus was attenuated by
introducing mutations that had been found in an egg-adapted, avirulent virus. The V protein therefore seems to be potentially functional in
the highly virulent Hamamatsu strain and to be prominent if virus replication is restricted.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Sendai virus (SeV), also called murine parainfluenza
virus type 1, belongs to the family Paramyxoviridae and
causes respiratory illness in animals. Although the natural
ecology of SeV is not well known, it occasionally causes
devastating epidemics in rodents in animal facilities. Thus,
Sendai virus infection in mice is an appropriate model for
studying virus pneumo-pathogenesis in animals. We iso-
lated a field strain, the Hamamatsu strain, from an epidemic
in an animal facility of the Hamamatsu Medical College in
Japan in 1976 (Kiyotani et al., 1990). In an infection model
using young mice, aged 3 weeks, the Hamamatsu strain was
sufficiently virulent to exhibit a 50% mouse lethal dose
(MLD50) of ca. 1.3  102 cell infectious units (CIU)/mouse
(Kiyotani et al., 2001). On the other hand, SeV also prop-
agates well in embryonated chicken eggs, and laboratory
stocks have usually been maintained by passages in eggs.
However, repeated passages of SeV in eggs alter the nature
of the virus: adaptation to chicken eggs and attenuation of
virulence to mice. When serially passaged in eggs 30 times,
the virulence of the Hamamatsu strain became attenuated by
as much as 600-fold, exhibiting an MLD50 of 7.9  104
CIU/mouse (Kiyotani et al., 2001). Furthermore, a labora-
tory strain, the Z strain, which has been maintained in eggs
over a period of several decades, has an MLD50 value of 7.9
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 105 CIU/mouse in the infection model and is extremely
avirulent (Sakaguchi et al., 1994). Side-by-side comparison
of the Hamamatsu strain and the Z strain by infecting mice
with 103 CIU/mouse clearly showed differences in virus
replication in mouse lungs, consolidation scores, and fatal-
ity (Sakaguchi et al., 1994). Therefore, it would be more
feasible to use a field isolate to better understand the natural
course of infection and pathogenesis of SeV.
SeV possesses six structural proteins: nucleoprotein (N),
phosphoprotein (P), matrix protein (M), fusion protein (F),
hemagglutinin-neuraminidase (HN), and large protein (L).
These are essential proteins for replication in cultured cells.
The nonstructural accessory proteins, V and C proteins, are
also expressed in infected cells. The V protein is generated
from a P gene transcript subpopulation that has an insertion
of a nontemplated G residue at a specific editing site and
accounts for 25% of the transcripts. Thus, the V protein
consists of a P/V common amino-terminal half and a V
unique carboxyl-terminal half. On the other hand, C’, C, Y1,
and Y2 proteins, collectively called C proteins, are encoded
by an overlapping, shifted ORF of the upstream regions of
the P and V mRNAs with multiple translational start codons
and a common termination codon (Lamb and Kolakofsky,
2001; Nagai, 1999).
A phenotype of a V-knockout virus indicated that the V
protein has a luxury function required for in vivo replication
and pathogenesis in mice, although the V protein is not
essential for virus replication in cultured cells (Kato et al.,
1997a). This function has been shown to depend on the V
unique carboxyl-terminal region (Kato et al., 1997b). Fif-
teen conserved amino acids, including 7 cysteine residues,
in the region are essential for the function, probably via
maintenance of protein conformation related to zinc ion
binding (Fukuhara et al., 2002; Huang et al., 2000). How-
ever, all previous studies on the function of the V protein
have been carried out using a laboratory strain, the Z strain.
In the present study, we reexamined the role of the V protein
by generating a V-knockout virus using a virus recovery
system of the Hamamatsu strain we have reported recently
(Fujii et al., 2002a).
Results
Generation of a V-knockout field isolate and infection
in mice
We generated a recombinant V-knockout virus of the
Hamamatsu strain, rSeVH-V(), that possesses two nucle-
otide substitutions that disrupts the RNA editing signal to
generate V mRNA without changing the P polypeptide
encoded in an overlapping reading frame. CV1 cells were
infected with rSeVH-V(), and proteins were analyzed by
metabolic labeling and SDS–PAGE (Fig. 1A). rSeVH-V()
lacked the V protein as shown by immunoprecipitation with
anti-V antiserum, while the other viral proteins were syn-
thesized as a wild-type virus, rSeVH-WT, as shown by
precipitation with anti-SeV antiserum.
Virus growth in CV1 cells was examined. There was no
significant difference between the rate of growth of rSeVH-
V() and that of rSeVH-WT, although rSeVH-V() grew
a little more rapidly than rSeVH-WT at m.o.i.s of 10 and
0.001 (Figs. 1B and C). This finding is consistent with the
result obtained for the Z strain (Kato et al., 1997a) and is
probably because of acceleration of viral RNA synthesis
due to loss of the V protein, which has been shown to
suppress virus genome amplification in an RNA replication
system in vitro (Curran et al., 1991).
Growth of the virus in mice was then investigated.
Fig. 1. Protein synthesis and virus replication of rSeVH-V() in CV1 cells. (A) CV1 cells were infected with rSeVH-V() as well as rSeVH-WT at an m.o.i.
of 20 and incubated for 7 h. The cells were then metabolically labeled with [35S]cysteine–methionine for 20 min. Proteins were analyzed by immunopre-
cipitation with anti-SeV antibody (SeV) or anti-V antibody (V) and SDS–PAGE using an 11% gel. Radioactive bands were visualized using a Bioimaging
analyzer. Positions of SeV proteins are shown in the figure, and F0 indicates the precursor of the F protein. UI, uninfected cells. (B and C) CV1 cells were
infected with SeV at an m.o.i. of 10 (B) or 0.001 (C) and kept in a medium containing 10 g/ml of trypsin. A part of the medium was harvested at each
indicated time, and infectivity in the medium was measured. Each value is the mean from duplicate dishes.
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rSeVH-V() propagated in mouse lungs as efficiently as, or
even more rapidly than, rSeVH-WT, although the rate of
growth of rSeVH-V() declined earlier than that of
rSeVH-WT (Fig. 2). Correspondingly, MLD50 values of
rSeVH-V() and rSeVH-WT are almost similar (Table 1),
demonstrating that rSeVH-V() was as pathogenic as
rSeVH-WT. The efficient growth and high pathogenicity of
rSeVH-V() were in contrast to the suppressed growth and
low pathogenicity of the V-knockout virus of the Z strain
(Kato et al., 1997a), manifesting nonsense of the V protein
of the Hamamatsu strain in this infection model.
Switching the V unique domain
Regarding the discrepancy between the Hamamatsu and
Z strains, we carried out an experiment to determine
whether the V unique region of the Hamamatsu strain,
which is essential for its function, was active in itself in
facilitating virus growth in mice by replacing the region of
the Z strain with that of the Hamamatsu strain. Several
amino acids in the V unique region of the Hamamatsu strain
are different from those in the V unique region of the Z
strain and it is known that even a single point mutation of
the V unique domain can disturb the function of the V
protein (Fukuhara et al., 2002; Huang et al., 2000). The
generated recombinant virus. rSeVZ-VuH, possesses a chi-
meric V protein, the N-terminal P/V common half derived
from the Z strain and the C-terminal V unique half derived
from the Hamamatsu strain (Fig. 3A), and all of the other
proteins are from the Z strain.
Fig. 2. Viral replication in mice infected with rSeVH-V(). Three-week-
old ICR mice were infected intranasally with SeV at 103 CIU/mouse, and
three mice in each group were sacrificed at the indicated days and exam-
ined for viral infectivity. Each value is the mean from three mice, and error
bars represent the range of standard deviations.
Table 1
MLD50 values of SeV mutantsa
Virus MLD50 (relative pathogenicity)
Hamamatsu strain-derived virus
rSeVH-WT 2.0  102 (1.00)
rSeVH-V() 1.3  102 (1.54)
rSeVH-20A24A 3.2  103 (0.06) (1.00)b
rSeVH-20A24A-V() 5.0  105 (0.0004) (0.006)b
Z strain-derived virus
rSeVZ-WT 7.9  105 (1.00)
rSeVZ-VuH 7.9  105 (1.00)
rSeVZ-V() 1.3  108 (0.006)
rSeVZ-VC 2.0  107 (0.04)
a Values are MLD50 values of SeV mutants (CIU/mouse). The relative-
pathogenicity is the ratio of the reciprocal of the MLD50 value to that of
rSeVH-WT or rSeVZ-WT (MLD50 of rSeVH-WT or rSeVZ-WT)/(MLD50
of a virus) and is shown in parentheses.
b Relative pathogenicity against rSeVH-20A24A.
Fig. 3. (A) A schematic view of V proteins of the Z, Hamamatsu, and VuH
viruses. The virus rSeVZ-VuH possesses a chimeric V protein with the
C-terminal V unique half of the Hamamatsu strain in the Z strain back-
ground. (B) Protein synthesis of SeV in CV1 cells. CV1 cells were infected
with SeV at an m.o.i. of 20, and proteins were labeled, immunoprecipi-
tated, and analyzed as described in the legend of Fig. 1. UI, uninfected
cells.
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The result of protein labeling and SDS-PAGE showed
that the V protein of rSeVZ-VuH migrated faster than did
that of rSeVZ-WT (Fig. 3B). This is because the V protein
of the Hamamatsu strain is shorter by 15 amino acids than
the Z strain (Fig. 3A; Fujii et al., 2001). Virus growth in
mouse lungs (Fig. 4) indicates that rSeVZ-WT and rSeVH-
VuH propagate in mouse lungs in a similar manner, al-
though rSeVZ-VC and rSeVZ-V(), which lacks the re-
spective V unique region and the entire V protein, were
cleared from mouse lungs rapidly as described previously
(Kato et al., 1997a; 1997b). The MLD50 value of rSeVZ-
VuH was also equivalent to that of rSeVZ-WT, but not to
those of rSeVZ-V() and rSeVZ-VC (Table 1).
These results show that the V unique region of the
Hamamatsu strain can substitute for that of the Z strain in
supporting virus replication in mouse lungs and in eliciting
virus pathogenicity in mice and that the V unique region of
the Hamamatsu strain is functional in a Z strain background.
The results cannot therefore explain the dispensability of the
V protein for efficient growth of the Hamamatsu strain in
mouse lungs.
The function of V protein is masked by efficient
replication of the Hamamatsu strain
We hypothesized that the Hamamatsu strain replicates
too efficiently to require the V protein function in mice. We
thus tried to attenuate virus replication in mice by introduc-
ing mutations. We previously reported mutations associated
with adaptation to embryonated eggs and attenuation of
virulence to mice (Fujii et al., 2002b). Characteristic muta-
tions with these associations are a set of U20A and U24A
mutations in the leader, the promoter of transcription and
replication. rSeVH-20A24A, which has U20A and U24A
mutations in the wild-type background, replicates defec-
tively both in mouse lungs and in a primary culture of
mouse pulmonary epithelial cells, while the virus replicates
in chick embryo fibroblasts as efficiently as the wild type
does, demonstrating host dependence in virus replication
(Fujii et al., 2002a).
Virus growth of rSeVH-20A24A was slightly impaired
at m.o.i.s of both 10 and 0.001 in CV1 cells compared with
the parent virus, rSeVH-WT (Figs. 5B and C). Pulse label-
ing of viral proteins at 7 h after infection at a high m.o.i.
demonstrated faint bands, indicating slight attenuation of
virus growth (Fig. 5A). We introduced 20A and 24A mu-
Fig. 4. Viral replication in mice infected with rSeVZ-VuH. Three-week-old
ICR mice were infected intranasally with SeV at 106 CIU/mouse, and three
mice in each group were sacrificed at the days indicated and examined for
viral infectivity. Each value is the mean from three mice, and error bars
represent the range of standard deviations.
Fig. 5. Protein synthesis and virus replication of rSeVH-20A24A-V() in CV1 cells. (A) CV1 cells were infected with SeV at an m.o.i. of 20, and proteins
were labeled, immunoprecipitated, and analyzed as described in the legend of Fig. 1. UI, uninfected cells. (B and C) CV1 cells were infected with SeV at
an m.o.i. of 10 (B) or 0.001 (C) and maintained in a medium containing 10 g/ml of trypsin. A part of the medium was harvested at each indicated time,
and infectivity in the medium was measured. Each value is the mean from duplicate dishes.
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tations into rSeVH-V(), generating rSeVH-20A24A-
V() (Fig. 5A). rSeVH-20A24A-V() replicated in a man-
ner similar to rSeVH-20A24A at an input m.o.i. of 10 and
replicated a little defectively at an m.o.i. of 0.001 (Figs. 5B
and C). These results show that rSeVH-20A24A and
rSeVH-20A24A-V() can replicate in CV1 cells with a
similar degree of efficiency.
rSeVH-WT replicated efficiently in mouse lungs (Figs. 2
and 6), and consolidation scores increased with the passage
of time, ending with the death of all of the infected mice
(Fig. 6), while its promoter mutant, rSeVH-20A24A, repli-
cated inefficiently in mouse lungs, causing low consolida-
tion scores and survival of all of the mice (Fig. 6), as shown
previously (Fujii et al., 2002a). On the other hand, rSeVH-
20A24A-V() was more rapidly cleared from lungs after 2
days of virus inoculation (Fig. 6), indicating the requirement
of the V protein for efficient replication of the virus with the
20A24A mutation in mice.
MLD50 values indicate that the relative pathogenicity of
rSeVH-20A24A-V() was 0.006 compared with that of
rSeVH-20A24A (Table 1), showing that a defect in the V
protein in the presence of the 20A24A mutation caused a
156-fold atenuation of virulence. The virus growth pattern
and attenuation of virulence are similar to those of a labo-
ratory strain, the Z strain (Kato et al., 1997a), in which a
defect in the V protein also caused a 156-fold attenuation of
virulence (Table 1), although virus clearance started on the
second day after infection in the Hamamatsu strain, 1 day
later than that in the case of the Z strain (Fig. 4).
Discussion
SeV V protein is essential for efficient virus replication
and pathogenesis in mice, while the V protein is not essen-
tial for virus replication in cultured cells. This indicates that
the V protein has a function in facilitating virus propagation
in mice but not in cultured cells. However, the mechanism
of this facilitation is not well understood. One possibility is
that the V protein antagonizes interferon action. The V
protein of the genus Rubulavirus of the family Paramyxo-
viridae, including viruses such as simian virus 5, human
parainfluenza virus type 2, and mumps virus, has been
clearly shown to antagonize interferon action in infected
cells through proteasome-mediated degradation of STAT
proteins (Didcock et al., 1999; Kubota et al., 2001; Nishio et
al., 2001; Parisien et al., 2001; Young et al., 2000). How-
ever, the V protein of SeV, a member of the genus Respi-
rovirus, does not antagonize interferon, whereas SeV C
proteins have been shown to antagonize interferon by re-
ducing functional STAT1 (Garcin et al., 1999; Gotoh et al.,
1999). Recently, Poole et al. 2002 have demonstrated that
the SeV V protein can inhibit interferon induction. In this
case, secretion of interferon is expected to increase in a
V-knockout virus infection and to inhibit virus growth.
However, it is thought that growth restriction of the V-
knockout Z strain is not mediated by the interferon /
receptor, because growth restriction was also observed in
interferon / receptor-knockout mice (Kiyotani et al., un-
published observation). The link between the inhibition of
interferon induction and the V protein activity facilitating
virus replication in mice remains to be clarified.
In the present study, we generated a V-knockout SeV
derived from a virulent field isolate, the Hamamatsu strain,
as an appropriate model for studying the natural course of
infection of SeV in mice. In infection to mice, an unex-
pected result was obtained in contrast to that of a laboratory
strain; the V-knockout virus also replicated slightly more
rapidly in mouse lungs and was as virulent as, or even more
virulent than, the parent V() virus. It appears that the
pattern of virus replication in mice is similar to that in
cultured cells, although the virus was cleared from lungs a
little earlier than the wild type. Switching of the functionally
important V unique region demonstrated that this region of
the Hamamatsu strain was also functional in a Z strain
background. It thus appears that the V protein is not essen-
tial for mouse pathogenesis of a field isolate. However, the
V protein facilitated virus growth and enhanced virulence in
mice when the virulence of the virus was attenuated by
introducing mutations that had been found in an egg-
adapted avirulent virus. This result suggests that the V
protein function is masked by extraordinarily efficient rep-
lication of the Hamamatsu strain in mouse lungs but is
prominent when virus replication is restricted. Another pos-
sibility is that the introduced leader mutations, U20A and
U24A, which are related to host dependence of virus growth
Fig. 6. Viral replication, lung consolidation, and body weight gain in mice
infected with rSeVH-20A24A-V(). Three-week-old ICR mice were in-
fected intranasally with SeV at 103 CIU/mouse, and three mice were
weighed daily. One dot shows a mouse, and the plus sign indicates the
death of a mouse. Three mice in each group were sacrificed at the days
indicated and examined for lung consolidation and viral infectivity. Each
line is based on the mean of three mice.
585T. Sakaguchi et al. / Virology 313 (2003) 581–587
(Fujii et al., 2002a), result in specific requirement of the V
protein for efficient replication of the virus.
Is the SeV V protein not essential in the natural course of
infection then? The present work showed that the V protein
was not essential in infection in young mice (3 weeks old),
in which fatal infection can occur due to the high level of
sensitivity. On the other hand, when virus replication was
restricted by a mutation, the V protein acquired importance
in viral pathogenesis. We speculate that the V protein has
the potential to facilitate virus growth in mice and that a
hidden function of the V protein may emerge if virus rep-
lication is restricted for some reason. To test this hypothesis,
we compared virus replications of rSeVH-WT and rSeVH-
V() in adult mice of more advanced age (9 weeks old) and
in Crj:Wistar rats (6 weeks old), in which SeV infection is
never fatal. However, the V-knockout Hamamatsu strain
grew well and was as pathogenic as the V() virus in these
animals (Kiyotani et al., unpublished observations). There-
fore, evidence supporting our speculation has not yet been
obtained. It would be interesting to further examine the
pathogenicities of various virus constructs in other strains of
mice or rodents. Differences in susceptibility may shed
further light on the various functions of the V protein.
Materials and methods
Cells and viruses
CV1 and LLC-MK2 cells were grown in Eagle’s minimal
essential medium (MEM) supplemented with 10% fetal calf
serum and nonessential amino acids. SeV stocks were prop-
agated in embryonated chicken eggs, and their infectivity
was determined using an immunofluorescent infectious fo-
cus assay in LLC-MK2 cells (Kiyotani et al., 1990) and
expressed as CIU/ml.
Plasmid construction
To construct pSeVH-V(), the DNA fragment flanked
by SalI sites corresponding to the region 2075–4981 of the
genome was subcloned into the pGEM7 vector. Two nucle-
otide substitutions, U at position 2788 to C and C at position
2791 to U, were introduced into the plasmid to disrupt the
RNA editing signal. The SalI fragment was then returned to
pSeVH, which contains the entire genomic cDNA of the
clone E0 of the Hamamatsu strain (Fujii et al., 2002a).
For pSeVZ-VuH, mutations were introduced into the
DNA fragment flanked by ClaI sites corresponding to the
region 2090–5335 of the genome of the SeV Z strain to
substitute six amino acids with those of the Hamamatsu
strain without changing the overlapping P polypeptide. The
changes included a substitution of the glutamine residue at
position 370 (of the V polypeptide) with a stop codon, since
the V protein of the Hamamatsu strain is shorter than that of
the Z strain due to the appearance of an early stop codon
(Fujii et al., 2001). The resultant plasmid, pSeVZ-VuH,
encodes the V unique region of the Hamamatsu strain in a
Z strain background. For pSeVH-20A24A-V(), a 644-bp
BsiWI–SphI fragment of pSeVH-V() containing the
leader sequence was replaced with that of pSeVH-20A24A
(Fujii et al., 2002a). The nucleotide sequence was confirmed
during recombination procedures by using an ABI 310 Ge-
netic Analyzer (PE Biosystems, Foster City, CA).
Recovery of SeV from cDNA
Recombinant SeV (rSeV) was recovered from pSeVH-
V(), pSeVZ-VuH, or pSeVH-20A24A-V() as described
previously (Fujii et al., 2002a; Kato et al., 1996). Briefly,
LLC-MK2 cells were infected with the T7 RNA polymer-
ase-expressing vaccinia virus vTF7.3 (a kind gift from Ber-
nard Moss, National Institute of Health) and subsequently
transfected with one of the pSeV plasmids and the three
plasmids pGEM-N, -P, and -L to support the initiation of the
SeV life cycle from cDNA. After a 48-h incubation, the cell
lysates were injected into embryonated chicken eggs and
incubated at 33°C for 3 days.
Nucleotide sequencing of the N, P, and L genes of
rSeVH-20A24A-V() revealed no DNA recombination be-
tween the genomic cDNA derived from the Hamamatsu
strain and the supporting plasmids containing the cDNA of
N, P, and L proteins derived from the Z strain. This elimi-
nated the possibility of a DNA homologous recombination,
which is facilitated by vaccinia virus, during virus recovery,
as shown previously (Garcin et al., 1995). The possibility of
a genetic recombination in rSeVH-20A24A was also ruled
out by sequencing of the N, P, and L genes in our previous
study (Fujii et al., 2002a).
Protein analysis by SDS–PAGE
Virus-infected cells were labeled with [35S] cysteine–
methionine ([35S]Pro-mix; 1.85 MBq/ml; Amersham Bio-
sciences, Piscataway, NJ) in cysteine- and methionine-free
Dulbecco’s modified MEM at 7 h postinfection for 20 min.
Polypeptides were then solubilized in a radioimmunopre-
cipitation assay buffer [10 mM Tris–HCl, pH 7.4, 1% Triton
X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl
sulfate (SDS), and 150 mM NaCl] and then immunopre-
cipitated with anti-SeV serum and analyzed by SDS–poly-
acrylamide gel electrophoresis (PAGE) using an 11% gel as
described previously (Sakaguchi et al., 1996). An autora-
diogram was analyzed by using a BAS2000 image analyzer
(Fuji Film, Tokyo, Japan).
Infection of cultured cells with SeV
Confluent CV1 cells in a 35-mm dish were inoculated
with SeV at an m.o.i. of 10 or 0.001. After 1-h adsorption,
the cells were washed with phosphate-buffered saline twice
and then incubated with 1 ml of MEM. The medium for a
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low m.o.i. infection contained 10 g/ml of trypsin (E.
Merck, Darmstadt, Germany). A part of the medium was
harvested at each indicated time, and infectivity in the
medium was measured after treatment with trypsin to ensure
cleavage activation of the F protein.
Infection of mice with SeV
Specific pathogen-free, 3-week-old male mice of the
ICR/Crj (CD-1) strain weighing 8 to 11 (purchased from
Charles River Japan, Inc., Atsugi, Japan) were used for
infection. For an assay of virus replication in mouse lungs,
mice were infected intranasally with a 25-l inoculum con-
taining 103 CIU of the Hamamatsu strain and its mutants or
106 CIU of the Z strain and its mutants under mild ether
anesthesia. At certain time intervals, mice were sacrificed
and lungs were homogenated in 1 ml of MEM by using a
mortar and pestle. After a low-speed centrifugation, infec-
tivity in the supernatant was measured.
Consolidation scores were marked by macroscopic ap-
pearance as described previously (Fujii et al., 2002a).
MLD50 was determined as described previously (Kiyotani
et al., 1990). All of the mice were kept under bioclean and
regulated conditions in the P3 facility for animal experi-
ments of Hiroshima University.
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